Stockhub

Atara Biotherapeutics, Inc. English (Q21874220)

Item Discussion
clinical-stage biotechnology company English
edit
Language Label Description Also known as
British English
No label defined
No description defined

    Statements

    instance of
    business
    0 references
    enterprise English
    0 references
    public company
    0 references
    headquarters location
    Q927122 (Deleted Item)
    0 references
    inception
    2012
    0 references
    industry
    biotechnology
    0 references
    Q162555 (Deleted Item)
    0 references
    multiple sclerosis
    0 references
    autoimmune disease
    0 references
    Q27723394 (Deleted Item)
    0 references
    Legal Entity Identifier
    549300WBXUXZRE03MS38
    0 references
    PermID
    5037937603
    0 references
    field of work
    Immunotherapy
    0 references
    Q193529 (Deleted Item)
    0 references
    Epstein–Barr virus English
    0 references
    stock exchange
    NASDAQ
    ticker symbol
    ATRA
    0 references
    legal form
    public company
    0 references
    part of
    NASDAQ Biotechnology Index English
    0 references
    Russell 2000 English
    0 references
    GRID ID
    grid.508098.c
    1 reference
    stated in
    Q96758688 (Deleted Item)
    ROR ID
    04h82wq77
    0 references
    ISNI
    0000 0004 7413 1708
    1 reference
    ROR ID
    04h82wq77
    retrieved
    25 July 2020
    Crossref funder ID
    100016253
    0 references
    Golden ID
    Atara_Biotherapeutics-VWRB854
    1 reference
    retrieved
    10 September 2022
    reference URL
    https://golden.com/wiki/Atara_Biotherapeutics-VWRB854
     
    Retrieved from ‘https://stockhub.co/index.php?title=Item:Q21874220&oldid=109456’